A non-invasive, AI-based, wearable earpiece that continuously monitors brain activity to enable the early detection of seizure risk in real…
mjn-neuro1 December, 2025
PRESS RELEASE The CNS specialist Neuraxpharm has signed a commercialisation agreement with mjn-neuro with exclusivity in Europe Düsseldorf and Barcelona…
mjn-neuro25 October, 2022
Part of our team was present to be able to observe, test and analyze the new tools on offer at…
mjn-neuro21 March, 2022
We are coming to the end of 2020, we would like to congratulate everyone who has helps us in our…
mjn-neuro1 January, 2021
Yes! We did it! We have been able to “steal” few minutes from our CEO, David Blánquez. You started as…
mjn-neuro7 December, 2020
We introduce you to Xavier, the COO (Chief Operating Officer) of MJN. Xavier has been one of the founders of…
mjn-neuro30 November, 2020
Hello Jordina, we are with the CSO of mjn-neuro. She defines herself as an engineer, innovator, and serial entrepreneur.
mjn-neuro6 October, 2020
When we started our project in 2012, we knew that only a highly advanced technological solution would be able to…
mjn-neuro26 June, 2020
The EIT Health BRIDGEHEAD program aims to help health projects grow their businesses and validated products beyond the markets. BRIDGEHEAD…
mjn-neuro10 June, 2020
